{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:20:51Z","timestamp":1772119251026,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1517,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.fertnstert.2017.12.021","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T08:49:36Z","timestamp":1522226976000},"page":"633-637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in\u00a0vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist"],"prefix":"10.1016","volume":"109","author":[{"given":"Brianna M.","family":"Lyttle Schumacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Mersereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Z.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2017.12.021_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/humupd\/dml001","article-title":"GnRH antagonists in ovarian stimulation for IVF","volume":"12","author":"Tarlatzis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.12.021_bib2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotropin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.12.021_bib3","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/humrep\/17.11.2842","article-title":"Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study","volume":"17","author":"Ludwig","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.12.021_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2010.05.052","article-title":"Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in\u00a0vitro fertilization: a randomized control trial","volume":"95","author":"Kolibianakis","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.12.021_bib5","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.fertnstert.2009.05.083","article-title":"The use of lead follicle diameter to initiate gonadotropin-releasing hormone antagonist does not affect in\u00a0vitro fertilization clinical pregnancy, implantation, or live birth rates: a prospective, randomized study","volume":"92","author":"Dayal","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.12.021_bib6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/0300060517704140","article-title":"Predicting the outcome of different protocols of in\u00a0vitro fertilization with anti-Muullerian hormone levels in patients with polycystic ovarian syndrome","volume":"45","author":"Chen","year":"2017","journal-title":"J Int Med Res"},{"key":"10.1016\/j.fertnstert.2017.12.021_bib7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/humrep\/dex095","article-title":"Supraphysiologic estradiol is an independent predictor of low birth weight in full-term singletons born after fresh embryo transfer","volume":"32","author":"Pereira","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.12.021_bib8","unstructured":"American Society for Reproductive Medicine. Female Infertility Pharmacotherapy - Stimulation Protocols. In, 2016."},{"issue":"4","key":"10.1016\/j.fertnstert.2017.12.021_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","author":"Al-Inany","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2017.12.021_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rbmo.2017.04.010","article-title":"High oestradiol concentration after ovarian stimulation is associated with lower maternal serum beta-HCG concentration and neonatal birth weight","volume":"25","author":"Liu","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2017.12.021_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/humrep\/15.6.1211","article-title":"Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonist","volume":"15","author":"Hernandez","year":"2000","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217321623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217321623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:52:14Z","timestamp":1767113534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028217321623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0015028217321623"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.12.021","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in\u00a0vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}